Eileen Hsich, MD

216.444.7527

Eileen Hsich, MD
Department: Cardiovascular Medicine
Location: Cleveland Clinic Main Campus
Mail Code J3-4
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.7527
DeskDesk:216.444.7527
WorkFax:216.445.6197
Eileen Hsich, MD
Department: Nuclear Medicine
Location: Cleveland Clinic Main Campus
Mail Code J3-4
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.7527
DeskDesk:216.444.6744
WorkFax:216.445.6197
Eileen Hsich, MD
Department: Critical Care Center
Location: Cleveland Clinic Main Campus
Mail Code J3-4
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.7527
DeskDesk:216.444.6744
WorkFax:216.445.6197
Eileen Hsich, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code J3-4
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.7527
DeskDesk:216.444.6744
WorkFax:216.445.6197
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Dr. Eileen Hsich is the Director of the Women’s Heart Failure clinic and Associate Medical Director for the Heart Transplant Program at the Cleveland Clinic. She specializes in heart failure in women, heart transplantation, and nuclear cardiology.

Dr. Hsich received her medical degree from The Johns Hopkins University School of Medicine and completed her cardiology fellowship at Tufts-New England Medical Center (NEMC) in Boston.  She did cardiovascular basic science research both at the National Institutes of Health (NIH) and Tufts- New England Medical Center where she received the National Research Service Award for Individual Postdoctoral Fellows.   She was appointed to The Cleveland Clinic in 2004 after completing her clinical training in heart failure/ heart transplantation at Massachusetts General Hospital in Boston. In 2006, she was appointed Assistant Professor of Medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. 

Dr. Hsich has published in many high impact journals.  Her research interests center on sex differences in heart failure management and clinical outcome. She uses institutional and national databases to explore these topics.  She has also served as the co-principal investigator on multi-center clinical trials. 

Dr . Hsich is a member of American Heart Association, American College of Cardiology, American Society of Nuclear Cardiology, International Society for Heart & Lung Transplant, and Heart Failure Society of America.

Education & Fellowships

Fellowship - Massachusetts General Hospital
Heart Failure/Cardiac Transplantation
Boston, MA USA
2004
Fellowship - New England Medical Center
Cardiovascular Medicine
Boston, MA USA
2003
Residency - National Heart, Lung and Blood Institute
Clinical Research
Bethesda, MD USA
1999
Residency - Barnes-Jewish Hospital
Internal Medicine
St. Louis, MO USA
1996
Medical School - Johns Hopkins University School of Medicine
Baltimore, MD USA
1994
Undergraduate - Brandeis University
Waltham, MA USA
1990

Certifications

  • Internal Medicine- Cardiovascular Disease
  • Certification Board of Nuclear Cardiology- Nuclear Cardiology

Specialty Interests

Cardiomyopathy, cardiac tumors, heart failure, heart transplantation, ventricular assist device, heart failure in women

Awards & Honors

AHA grant awarded for creating a model to predict survival in ambulatory women and men with severe systolic heart failure

Memberships

  • American Heart Association
  • American College of Cardiology
  • American Society of Nuclear Cardiology
  • International Society for Heart & Lung Transplant
  • Heart Failure Society of America

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/25/2014, Dr. Hsich has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site